Media stories about Strata Skin Sciences (NASDAQ:SSKN) have been trending somewhat positive on Wednesday, Accern Sentiment reports. The research firm ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Strata Skin Sciences earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news headlines about the medical device company an impact score of 45.7184501173404 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
SSKN has been the subject of a number of research reports. HC Wainwright set a $12.00 price target on shares of Strata Skin Sciences and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Zacks Investment Research downgraded shares of Strata Skin Sciences from a “hold” rating to a “sell” rating in a research note on Thursday, November 16th. Finally, ValuEngine downgraded shares of Strata Skin Sciences from a “sell” rating to a “strong sell” rating in a research note on Monday, October 2nd.
Strata Skin Sciences (NASDAQ:SSKN) traded down $0.02 during mid-day trading on Wednesday, reaching $1.24. 37,700 shares of the company were exchanged, compared to its average volume of 122,817. Strata Skin Sciences has a 12 month low of $1.06 and a 12 month high of $5.40. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.37.
TRADEMARK VIOLATION WARNING: “Strata Skin Sciences (SSKN) Receives Daily News Impact Score of 0.05” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2017/12/06/strata-skin-sciences-sskn-receives-daily-news-impact-score-of-0-05.html.
Strata Skin Sciences Company Profile
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.